Company news

Concord Biotech Ltd. news in 2026

Concord Biotech Ltd.'s news releases, calls and decks from 2026, newest first.

View company

Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility

June 25, 2026

Bertelsmann says US authorities have approved BMG/Concord merger

June 17, 2026

Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility

June 12, 2026

Trade Spotlight: How should you trade Concord Biotech, Jindal Steel, Axis Bank, Aegis Logistics, Raymond, and others on June 11?

June 10, 2026

Concord Biotech surges over 5% after USFDA approval for Tofacitinib tablets

June 10, 2026

Concord Biotech shares jump 8% after US FDA clears firm's new drug

June 3, 2026

Concord Biotech gets FDA nod for immunosuppressant mycophenolate mofetil

June 2, 2026

CONCORDBIO: Revenue declined 12% in FY 2026, but strong growth and margin improvement are expected in FY 2027

June 1, 2026

CONCORDBIO: Revenue and profit fell in FY26, but new launches and compliance set up strong FY27 growth

May 30, 2026

Concord Biotech Q4 profit slides 37%, margins shrink; declares ₹7.55 dividend

May 29, 2026

Trade Spotlight: How should you trade Concord Biotech, Max Healthcare Institute, Laurus Labs, Bank of Maharashtra, Castrol India, and others on May 5?

May 4, 2026

ZAWYA: Cairo Metro Line 4 first phase to open in 2028 as tunnelling milestone reached

April 29, 2026

Penguin Random House owner Bertelsmann Combines Music Arm With Concord — Update

April 28, 2026

CONCORDBIO: Q3 revenue up 14% YoY, API volumes strong, injectables and CDMO to drive future growth

February 12, 2026

CONCORDBIO: Strong revenue growth and stable profits, with a one-time charge for regulatory changes

February 11, 2026

Mergers and acquisitions

January 30, 2026

Bertelsmann's BMG weighs possible acquisition of Concord, Bloomberg News reports

January 29, 2026

Calls in 2026

Decks in 2026